Login / Signup

Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.

Xin JiangYong-Jian ZhuYu-Ping ZhouFu-Hua PengLan WangWei MaYun-Shan CaoXin PanGang-Cheng ZhangFeng ZhangFen-Ling FanBing-Xiang WuWei HuangZhen-Wen YangCheng HongMeng-Tao LiYi-Ning WangXi-Qi XuDuo-Lao WangShu-Yang ZhangZhi-Cheng Jing
Published in: European heart journal (2021)
Patients with TA-PH were predominantly female and had severely compromised haemodynamics. More than 80% of patients in our cohort survived for at least 3 years. Medical treatment was based on investigators' personal opinions, and no clear risk-to-benefit ratio can be derived from the presented data.
Keyphrases
  • pulmonary hypertension
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • healthcare
  • peritoneal dialysis
  • pulmonary artery
  • combination therapy
  • smoking cessation